Drugs / AZM
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02543073 Background | Sep 2014 → Dec 2017 | bronchiolitis obliterans syndrome, disease related to hematopoietic stem cell transplant | Nanfang Hospital, Southern Medical University | Unknown | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02543073 ↗ |